NEW YORK, Sept.18 - Genomic drug target discovery company Oxagen of Milton Park, UK is seeking to raise as much 30 million pounds ($42 million) in private financing and is considering an initial public offering for 2001, Reuters reported Monday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.